3 excellent ASX shares to buy for your SMSF

Analysts think these shares could be top picks for SMSF investors. Let's find out why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

For Australia's growing community of self-managed super fund (SMSF) trustees, long-term thinking is everything.

With over 625,000 SMSFs holding a collective $990 billion in assets as of 30 June 2024, according to the ATO, more Australians than ever are taking control of their retirement outcomes — and doing so with an eye on quality, sustainability, and growth.

If you're managing your own super, choosing the right ASX shares can make a significant difference to your wealth over time.

The goal? Own companies with durable advantages, strong leadership, and clear growth runways that can compound for years to come.

With that in mind, here are three excellent ASX shares that analysts think could make strong long-term additions to any SMSF portfolio. They are as follows:

Two people having a meeting using a laptop and tablet to discuss Seven West Media's balance sheet

Image source: Getty Images

Goodman Group (ASX: GMG)

Goodman Group is a standout in the property space. Instead of shopping centres or office towers, it focuses on high-demand industrial assets like warehouses, distribution centres, and data infrastructure.

It is a pure play on the rise of e-commerce, supply chain modernisation, and the cloud economy. Major global names like Amazon and Microsoft are Goodman tenants, and the company has a development pipeline geared towards supporting data centre.

Citi currently rates Goodman as a buy with a $40.00 price target.

ResMed Inc. (ASX: RMD)

Another ASX SMSF share to look at is ResMed. It is a global leader in sleep and respiratory medicine, known for its innovative CPAP machines and digital health solutions. The company's technology helps millions of people around the world manage sleep apnoea and chronic respiratory conditions — and demand is only rising.

For SMSF investors looking to invest in healthcare innovation with global scale and recurring revenue, ResMed ticks all the boxes.

Goldman Sachs rates the company very highly. It has a conviction buy rating and $49.30 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for an SMSF. It has grown into one of Australia and New Zealand's biggest tech success stories — and there's still a long road ahead. The company provides cloud-based accounting software to just over 4 million subscribers globally, with deep penetration across ANZ and increasing traction in key international markets.

Xero generates recurring, high-margin revenue, and while it's still investing for growth, the business is now focused on profitability and operating leverage. Its customer base of small and medium businesses is loyal, sticky, and growing — making it a compelling software-as-a-service (SaaS) play for long-term investors.

Goldman Sachs estimates that it has a 100 million total addressable market. This gives it a significant growth runway over the next decade or two.

It is for this reason that Goldman has a buy rating and $201.00 price target on its shares.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor James Mickleboro has positions in Goodman Group, ResMed, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Goodman Group, ResMed, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A young man talks tech on his phone while looking at a laptop with a financial graph superimposed across the image.
Growth Shares

3 ASX growth shares to buy with $10,000

Looking to add some growth shares to your portfolio? Here are three that brokers rate as buys.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 ASX 300 shares that could be much bigger in 5 years

Big returns could be on offer from these shares according to analysts.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

3 ASX shares tipped to grow 75% or more in the next 12 month!

These businesses may be significantly undervalued.

Read more »

A woman looks excited as she holds Australian dollars in the air.
Growth Shares

2 undervalued ASX shares to buy that experts think could deliver strong returns

A fund manager thinks these ASX shares could deliver great returns.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

5 ASX growth shares to buy and hold for 5 years

These shares could be destined for bright futures.

Read more »

A woman with a magnifying glass adjusts her glasses as she holds the glass to her computer screen and peers closely at it.
Growth Shares

3 ASX shares below $5 with huge potential

Some of the most interesting ASX shares are not the biggest, but those still early in their growth journey.

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Growth Shares

This could be the best ASX 300 stock buy today!

This seems like a great time to invest.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Growth Shares

Where to invest $10,000 in ASX shares in April

Wondering where to invest? Here are three picks to consider.

Read more »